These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 1155530)

  • 21. Midtrimester abortion induced by serial intramuscular injections of 15(S)-15-methyl-prostaglandin F2alpha.
    Lauersen NH; Wilson KH
    Am J Obstet Gynecol; 1975 Jan; 121(2):273-6. PubMed ID: 1115134
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prostaglandin E2 induced abortion with vaginal suppositories in a contraceptive diaphragm.
    Schulman H; Saldana L; Tsai T; Leibman T; Cunningham M; Randolph G
    Prostaglandins; 1974 Aug; 7(3):195-205. PubMed ID: 4415347
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison between intraamniotic PGF2 alpha and vaginal PGE2 for second-trimester abortion.
    Lebed JP; Rubin A; Millman AE
    Obstet Gynecol; 1980 Jul; 56(1):90-6. PubMed ID: 7383493
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-dose intravenous administration of prostaglandin E 2 and F 2 for the termination of midtrimester pregnancies.
    Hillier K; Embrey MP
    J Obstet Gynaecol Br Commonw; 1972 Jan; 79(1):14-22. PubMed ID: 5021725
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vaginally administered 16, 16-dimethyl-prostaglandin E2 as an agent for pre-operative cervical dilatation.
    Leader A; Bygdeman M; Gréen K; Martin JN; Wiqvist N
    Prostaglandins; 1975 Aug; 10(2):357-64. PubMed ID: 1178913
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Termination of midtrimester pregnancy by serial intramuscular injections of 15(S)-15-methyl-prostaglandin F2alpha.
    Lauersen NH; Wilson KH
    Am J Obstet Gynecol; 1976 Jan; 124(2):169-76. PubMed ID: 1247053
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Termination of pregnancy by extraamniotic prostaglandins and the synergistic action of oxytocin.
    Embrey MP; Hillier K; Mahendran P
    Adv Biosci; 1973; 9():507-13. PubMed ID: 4805861
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Letter: PGE2 as a vaginal abortifacient - diaphragm effect.
    Corson SL; Bolognese RJ
    Prostaglandins; 1975 Sep; 10(3):543-4. PubMed ID: 1197786
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Abortifacient efficacy of intravaginal prostaglandin F2 .
    Wentz AC; Austin K; King TM
    Am J Obstet Gynecol; 1973 Jan; 115(1):27-32. PubMed ID: 4681831
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of labor in patients with missed abortion and fetal death in utero with protaglandin E2 suppositories.
    Lauersen NH; Wilson KH
    Am J Obstet Gynecol; 1977 Mar; 127(6):609-11. PubMed ID: 557289
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Midtrimester pregnancy termination by intravaginal administration of prostaglandin E2.
    Surrago EJ; Robins J
    Contraception; 1982 Sep; 26(3):285-94. PubMed ID: 6756775
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The efficacy and safety of intramuscularly administered 15(S) 15 methyl prostaglandin E2 methyl ester for induction of artificial abortion.
    Brenner WE; Dingfelder R; Staurovsky LG
    Am J Obstet Gynecol; 1975 Sep; 123(1):19-29. PubMed ID: 1190275
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mid-second-trimester labor induction: concentrated oxytocin compared with prostaglandin E2 vaginal suppositories.
    Winkler CL; Gray SE; Hauth JC; Owen J; Tucker JM
    Obstet Gynecol; 1991 Feb; 77(2):297-300. PubMed ID: 1988897
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of abortion by vaginal administration of 15(s)15-methyl prostaglandin F2alpha methyl ester. A comparison of two delivery systems.
    Bygdeman M; Gréen K; Lundström V; Ramadan M; Fotiou S; Bergström S
    Prostaglandins; 1976; 12 Suppl():27-51. PubMed ID: 968064
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparative study of two types of prostaglandins for abortion during the second trimester.
    Rettenmaier MA; Hanson FW
    Surg Gynecol Obstet; 1983 May; 156(5):585-8. PubMed ID: 6573807
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of intrauterine fetal demise and missed abortion using prostaglandin E2 vaginal suppositories.
    Southern EM; Gutknecht GD
    Obstet Gynecol; 1976 May; 47(5):602-6. PubMed ID: 1264407
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Termination of early gestation with 9-deoxo-16,16-dimethyl-9-methylene prostaglandin E2.
    Brenner PF; Marrs RP; Roy S; Mishell DR
    Contraception; 1982 Sep; 26(3):261-77. PubMed ID: 6184197
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prostaglandin E2 suppositories as a second-trimester abortifacient.
    Rakhshani R; Grimes DA
    J Reprod Med; 1988 Oct; 33(10):817-20. PubMed ID: 3193412
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Midtrimester pregnancy termination with prostaglandin E2 vaginal suppositories.
    Hochman M; Laufe LE
    J Reprod Med; 1976 May; 16(5):263-8. PubMed ID: 933105
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interruption of pregnancy with vaginal suppositories containing 16,16-dimethyl-trans-delta 2-prostaglandin E1 methyl ester.
    Wagatsuma T; Tabuchi T; Tabei T; Kaku R
    Contraception; 1979 Jun; 19(6):591-7. PubMed ID: 487809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.